Exciting news today about stem cell treatments and stem cell therapy which are closer to the marketplace than most people think. Biotech company Athersys was just awarded another stem cell patent, this one to treat cardiovascular diseases such as myocardial infarction, or heart attack, congestive heart failure, myocardial ischemia and other heart conditions.
New Stem Cell Patent Good News for Cardiovascular Disease Sufferers
Follow Us!